Radiation Oncology/Therapy: Page 63

Cancer caused 4M years of lost life in U.S.
By Brian Casey
Cancer deaths resulted in more than 4 million potential years of life lost in the U.S. in 2017, according to a November 13 study in Cancer Epidemiology, Biomarkers & Prevention. While overall cancer mortality has gone down, the potential number of years of lost life has remained stable due to the growing U.S. population.
November 12, 2020
2020 07 15 23 29 3710 Cancer Cells Prostate 400
Varian teams up with oncology data curator
By AuntMinnie.com staff writers
Radiation oncology vendor Varian has completed a $10 million investment and signed a collaboration agreement with oncology clinical data curator Cota.
November 9, 2020
2020 01 30 01 49 9107 Varian Astro 2019 400
GE lands imaging deal with GenesisCare
By AuntMinnie.com staff writers
GE Healthcare has partnered with Australian cancer and cardiac care company GenesisCare to provide imaging services and equipment to more than 440 treatment centers worldwide.
November 8, 2020
2020 01 29 18 12 5932 Ge Rsna 2019 400
Cancer delays: Counting COVID-19's hidden costs
By Frances Rylands-Monk
A patient whose cancer treatment is delayed by even one month can face a mortality risk of up to 13% higher, a Canadian and U.K. study has found. The investigation, published online by BMJ on 4 November, was triggered by concerns about delays to cancer diagnosis and therapy during the pandemic.
November 8, 2020
2017 09 14 23 05 1167 Cancer Cell 400
Coding and documentation for Y-90 radioembolization
By Erin Stephens
The treatment of liver tumors using yttrium-90 (Y-90) radioembolization brings unusual challenges for interventional radiologists. Erin Stephens of Healthcare Administrative Partners describes how to overcome them.
November 8, 2020
2018 10 18 23 20 1387 Liver Cancer 400
ViewRay's revenue plummets in Q3
By AuntMinnie.com staff writers
Image-guided radiation therapy vendor ViewRay announced its revenue for the third quarter was nearly half of what it was a year ago.
November 5, 2020
2019 09 17 17 11 0207 Viewray Astro 2019
Isotopia partners with Y-mAbs on radioisotope
By AuntMinnie.com staff writers
Isotopia Molecular Imaging is collaborating with biopharmaceutical company Y-mAbs Therapeutics for the supply of the medical radioisotope no-carrier-added lutetium-177.
November 5, 2020
2019 10 25 00 49 3370 Hands Shaking2 400
Shine makes 1st commercial sales of Lu-177
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies made its first commercial sales of its lutetium-177 (Lu-177) therapeutic isotope to multiple customers.
November 3, 2020
2018 04 24 20 24 4264 Isotope 400
AI Metrics adds to coffers
By AuntMinnie.com staff writers
Artificial intelligence (AI) technology developer AI Metrics has received $1.7 million in investment by a group led by members of the Alabama Capital Network.
November 2, 2020
2019 11 05 22 41 9992 Dollar Sign Golden 400
Prelude highlights ASTRO data on breast cancer risk test
By AuntMinnie.com staff writers
Molecular diagnostics developer Prelude presented data at the American Society for Radiation Oncology (ASTRO) 2020 annual meeting showing that its DCISionRT test can reclassify breast cancer risk in women.
October 29, 2020
2016 10 05 17 45 45 493 Breast Cancer 400
Accuray's fiscal Q1 revenue declines
By AuntMinnie.com staff writers
Radiation oncology firm Accuray has released financial results for its first quarter of fiscal 2021 that show a drop in revenue from last year.
October 29, 2020
2019 09 17 16 01 9179 Accuray Astro 2019
Radiation therapy access grows, but not in rural areas
By AuntMinnie.com staff writers
The number of radiation therapy facilities in the U.S. has grown by 17% in recent years, but they tend to be based in more populated areas, so some rural patients may still be missing out, according to a new study presented at the American Society for Radiation Oncology annual meeting.
October 28, 2020
2019 09 16 03 57 7061 Astro 2019 400
Previous Page
Page 63 of 468
Next Page